SCHEMBL3084362

SCHEMBL3084362

Cc1cc(C)c2c(c1)C(c1ccc(O)cc1)(C1CCCCCC1)C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.42
GPR55 Q9Y2T6 2/20 0.42
HTT P42858 1/20 0.42
GPR35 Q9HC97 1/20 0.42
KMT2A Q03164 1/20 0.41
PKM P14618 1/20 0.36
ALDH1A1 P00352 4/20 0.35
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
MAPK10 P53779 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP19A1 P11511 2/20 0.33
TBXAS1 P24557 1/20 0.33
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
TAS1R3 Q7RTX0 2/20 0.32
TAS1R1 Q7RTX1 2/20 0.32
TAS1R2 Q8TE23 2/20 0.32
BRD4 O60885 2/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3090059 1.00 CNR1 (0.42) CNR1GPR55HTTGPR35KMT2A
SCHEMBL3084189 0.99 CNR1 (0.43) CNR1GPR55HTTGPR35KMT2A
SCHEMBL3089839 0.88 CNR1 (0.41) CNR1GPR55HTTGPR35PKM
SCHEMBL13145686 0.88 CNR1 (0.41) CNR1GPR55HTTGPR35ALDH1A1
SCHEMBL3086173 0.88 CNR1 (0.41) CNR1GPR55HTTGPR35PKM
SCHEMBL3078145 0.88 CNR1 (0.41) CNR1GPR55HTTGPR35ALDH1A1
SCHEMBL3085945 0.87 CNR1 (0.41) CNR1GPR55HTTGPR35PKM
SCHEMBL3080833 0.87 CNR1 (0.41) CNR1GPR55HTTGPR35KMT2A
SCHEMBL13145666 0.86 CNR1 (0.39) CNR1GPR55HTTGPR35KMT2A
SCHEMBL3085960 0.86 CNR1 (0.39) CNR1GPR55HTTGPR35KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US claimed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
WO-2008129075-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE-COMPOUNDS TOPOTARGET A/S (DK) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TPH2, TPH1, HTR2C CNR1 971/4885GPR55 1842/4885HTT 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.